GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ttk kinase domain with an inhibitor: 400740

Analyse Crystal structure of ttk kinase domain with an inhibitor: 400740 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4JT3
Type
protein
Length
254 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity protein kinase ttk
EC
2.7.12.1
UniProt
P33981
Ligands
1PH, PO4
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity protein kinase ttk (EC 2.7.12.1)protein25437% helix, 21% strandP33981

Ligands and binding sites

  • 1PH · 2-phenyl-N-[3-(3-sulfamoylphenyl)-2H-indazol-5-yl]acetamide · ligand · chains A
  • PO4 · Phosphate ion · ion · 4 copies · chains A
  • EDO · 1,2-ethanediol · additive · 10 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14200.720.82381PH, EDO

Compared structures

  • 4JT3 · Crystal Structure of TTK kinase domain with an inhibitor: 400740 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.